Financial Toxicity and Quality of Life in Patients With TGCT

Financial Toxicity and Quality of Life in Patients With TGCT

Other: Comprehensive Score for financial toxicity (COST)
Measure indirect and direct health care cost that burden patients and their loved ones.Other: Functional Assessment of Cancer Therapy: General (FACT-G)
General quality of life instrument
Other: EORTC QLQ C-30
Assess quality of life in cancer patients
Other: EORTC QLQ-TC26.
To measure disease and treatment related quality of life issues relevant to testicular cancer patients that were not explored in the QLQ-C30 questionnaire.

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 15, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments